The health condition known as low testosterone, or low T, has recently taken center stage, most likely due to television advertisements claiming a cure for low T symptoms. These symptoms…
Read More Testosterone gel lawsuits continue to mount against pharmaceutical companies, including AbbVie, the company behind Androgel, and Eli Lilly & Co, the manufacturer of Axiron. These lawsuits cite testosterone gel injuries.…
Read More The second Actos bladder cancer lawsuit is currently on trial in the Circuirt Court for the City of Baltimore. The plaintiffs in the case, the family of Diep An, a…
Read More As a national law firm that practices defective drug and personal injury litigation, Carey & Danis has worked on numerous cases where a pharmaceutical company misrepresented a product, and in…
Read More Should older men use testosterone applied to the skin, such as testosterone gel, or should they inject testosterone into their muscles? A new study published in April 2015 in the…
Read More A woman who participated in a Washington University School of Medicine study claims to have sustained permanent injuries from the intrauterine contraceptive device (IUD), Mirena. The research study supplied participants…
Read More In a recent financial report, Bayer, the pharmaceutical company behind the controversial contraceptive drug Yaz, published information showing that Yaz sales have been on the decline. According to Bayer's report…
Read More The German pharmaceutical company responsible for the anticoagulant drug, Pradaxa, offered a $650 million settlement package to wrap up thousands of Pradaxa lawsuits in the U.S. In the statement announcing…
Read More Two men over 40 used testosterone gel, considering it a way to restore youthfulness. One man suffered a spinal stroke; the other man experienced a bilateral pulmonary embolism. These two…
Read More The Ontario Superior Court of Justice has approved a Yaz and Yasmin class action lawsuit. The lawsuit includes all women residing in Ontario and Quebec who used Yaz and/or Yasmin…
Read More